A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma

Publisher: Karger

E-ISSN: 1423-0232|80|1-2|50-56

ISSN: 0030-2414

Source: Oncology, Vol.80, Iss.1-2, 2011-05, pp. : 50-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract